相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号:
717824-30-1
- 规格:
1mLx10mM(inDMSO)/1mg/5mg/10mg/25mg/50mg/100mg/200mg
| 规格: | 1mLx10mM(inDMSO) | 产品价格: | ¥463.0 |
|---|---|---|---|
| 规格: | 1mg | 产品价格: | ¥268.0 |
| 规格: | 5mg | 产品价格: | ¥596.0 |
| 规格: | 10mg | 产品价格: | ¥984.0 |
| 规格: | 25mg | 产品价格: | ¥1864.0 |
| 规格: | 50mg | 产品价格: | ¥2696.0 |
| 规格: | 100mg | 产品价格: | ¥3536.0 |
| 规格: | 200mg | 产品价格: | ¥4944.0 |
Product Introduction
Bioactivity
| 名称 | Vidofludimus |
| 描述 | Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH). |
| 激酶实验 | DHODH inhibition assay: In vitro DHODH inhibition assay mixture contains 50 μM decycloubiquinone, 100 μM dihydroorotate, and 60 μM 2,6-dichloroindophenol. The amount of enzyme is adjusted such that an average slope of approximately 0.2 AU/min will be achieved in the assay for the positive control (eg, without inhibitor). Measurements are conducted in 50 mM TrisHCl, 150 mM KCl, 0.1% Triton X-100, and pH 8.0 at 30°C in a final volume of 1 ml. The components are mixed, and the reaction is started by adding dihydroorotate. The reaction is followed spectrophotometrically by measuring the decrease in absorption at 600 nm for 2 minutes. The assay is linear in time and enzyme concentration. Inhibitory studies are conducted in a standard assay with additional variable amounts of inhibitor. For the determination of the IC50 values (concentration of inhibitor required for 50% inhibition), eight different inhibitor concentrations are applied. Each data point is recorded in triplicates on a single measurement day. |
| 体外活性 | Vidofludimus 通过抑制嘌呤的新生合成,以浓度依赖的方式抑制了植物血凝素刺激的PBMC增殖。[1] Vidofludimus 通过抑制STAT3和NF-κB的激活,减少了来自结肠条的IL-17分泌。[2] |
| 体内活性 | 在MRLlpr/lpr小鼠中,Vidofludimus(300 mg/kg,口服)减少了系统性自身免疫反应并改善了狼疮性肾炎。[1] 在大鼠中,Vidofludimus(60 mg/kg,口服)有效减少了宏观和组织学病理变化以及CD3+ T细胞的数量。[2] 在大鼠肾脏移植模型中,Vidofludimus(20 mg/kg,口服)延长了生存期,这与急性排斥反应的组织学迹象的改善是并行的。[3] |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+90% Corn Oil : 3.3 mg/mL (9.29 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+90% Saline : 10 mg/mL (28.14 mM), Suspension. DMSO : 127.5 mg/mL (358.79 mM), Sonication is recommended. Ethanol : 1 mg/mL (2.81 mM), Sonication is recommended. |
| 关键字 | Vidofludimus | SC-12267 | SC 12267 | RNASynthesis | RNA Synthesis | oral | NR1H4 | non-alcoholic fatty liver disease (NAFLD) | Interleukin Related | Interleukin | Inhibitor | inhibit | inflammatory bowel disease (IBD) | immunomodulatory | Human DHODH | FXR | fatty liver | farnesoid X receptor (FXR) | DNASynthesis | DNA/RNA Synthesis | DNA Synthesis | dihydroorotate dehydrogenase (DHODH) | Dihydroorotate Dehydrogenase | DHODH |
| 相关产品 | Rhamnose monohydrate | Kaolin | Guanidine hydrochloride | 1,4-Naphthoquinone | 5-Fluorouracil | Tributyrin | Adenine | Gluconate Calcium | 1,8-Cineole | Thymidine | D(+)-Raffinose pentahydrate | Hydroxypropyl Cellulose |
| 相关库 | Inhibitor Library | Lipid Metabolism Compound Library | Bioactive Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Ferroptosis Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Drug Library |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验网络 第十九章 杂环化合物和生物碱 杂环化合物在自然界分布很广,其数量几乎占已知有机化合物的三分之一,用途也很多。许多重要的物质如叶绿素、血红素、核酸以及临床应用的一些有显著疗效的天然药物和合成药物等,都含有杂环化合物的结构。生物碱多是中草药的有效成分,绝大多数是含氮的杂环化合物。本章内容与医学关系密切,具有重要意义。
分子中具有高能键的化合物。在生物体内主要有上式(Ⅰ)和(Ⅱ)两种结构的高能化合物。其作用为贮藏能量(例如 ATP、肌酸磷酸)和作为产生 ATP源的中间代谢产物(例如磷酸烯醇丙酮酸)以及合成反应的中间物质(例如酰基辅酶 A),在蛋白质的结构( conformation)变化周期的第一阶段上(例如钠钾 ATP酶的羧基磷酸中间体)也具有重要作用。多数高等化合物具有磷酸基,但也有例外。
由不同种元素组成的纯净物叫做化合物。化合物一般有固定的组成。化合物的组成一般可用化学式表示。化合物具有确定的物理性质和化学性质,不同于其组成元素的性质。化合物中的元素不能用简单的机械方法或物理方法分开,而必须用化学方法才能分离。
技术资料暂无技术资料 索取技术资料










